Bdh succinate is a pharmaceutical intermediate consisting of two molecules of a stereochemically defined amino alcohol derivative combined with succinic acid. It is primarily used in the manufacturing process of HIV protease inhibitors.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 183388-64-9
Carbamic acid, N-[(1S,3S,4S)-4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-, 1,1-dimethylethyl ester
Pharmaceutical intermediate for peptide synthesis
[2S,3S,5S]-2-Amino-3-hydroxy-5-tert-butyloxycarbonylamino-1,6-diphenylhexane succinate salt
Pharmaceutical intermediate
4,6-diamino-2-chloropyrimidine-5-carbonitrile
pharmaceutical intermediate
6-amino-5-methylnicotinonitrile
Pharmaceutical intermediate
5-Bromo-2-iodopyrimidine
Pharmaceutical intermediate
2-Amino-3-methyl-5-nitropyridine
pharmaceutical intermediate
1,6-Diphenylhexane
n.a
(3-(6-Phenylhexyl)phenyl)boronic acid
n.a
butanedioic acid;bis(tert-butyl N-[(2S,4S,5S)-5-amino-4-hydroxy-1,6-diphenylhexan-2-yl]carbamate)
LAGICBLJBHDBSG-VVQWQMBKSA-N
CC(C)(C)OC(=O)N[C@@H](CC1=CC=CC=C1)C[C@@H]([C@H](CC2=CC=CC=C2)N)O.CC(C)(C)OC(=O)N[C@@H](CC1=CC=CC=C1)C[C@@H]([C@H](CC2=CC=CC=C2)N)O.C(CC(=O)O)C(=O)O